Abstract
The development of convenient, safe, efficient, and effective delivery methods for large molecular weight drugs (including biologicals and vaccines) by non-parenteral administration routes continues to be an objective for a number of academic institutions and commercial organizations. Transdermal delivery of drugs is generally limited to small and potent molecules using conventional patch technology and passive diffusion mechanisms. Large molecular weight drugs are generally administered by intramuscular or subcutaneous routes of administration using the traditional needle and syringe, or in some cases using needle-less injector devices. Fear and pain are universal concerns in needle-based drug delivery, particularly in the pediatric population, and can make the experience of vaccination rather unpleasant. “Needle-phobia” is one of the major reasons for vaccine noncompliance, which can lead to less than optimal therapeutic outcomes. Noncompliance also contributes significantly to the direct and indirect economic burden on the patient and the health-care system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56:581–587
McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, Prausnitz MR (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA 100:13755–13760
Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, Daddona PE (2002) Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 19:63–70
Wang PM, Cornwell M, Hill J, Prausnitz MR (2006) Precise microinjection into skin using hollow microneedles. J Invest Dermatol 126:1080–1087
Xie Y, Xu B, Gao Y (2005) Controlled transdermal delivery of model drug compounds by mems microneedle array. Nanomedicine 1:184–190
Teo MA, Shearwood C, Ng KC, Lu J, Moochhala S (2005) In vitro and in vivo characterization of mems microneedles. Biomed Microdevices 7:47–52
Rajaraman S, Henderson HT (2005) A unique fabrication approach for microneedles using coherent porous silicon technology. Sens Actuators B 105:443–448
Zahn JD, Deshmukh A, Pisano AP, Liepmann D (2004) Continuous on-chip micropumping for microneedle enhanced drug delivery. Biomed Microdevices 6:183–190
Draize JH (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 83:377–390
Wendorf JR, Ghartey-Tagoe EB, Williams SC, Enioutina E, Singh P, Cleary GW (2011) Transdermal delivery of macromolecules using solid-state biodegradable microstructures. Pharm Res 28:22–30
Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP (2004) Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine 22:422–430
Henderson EA, Louie TJ, Ramotar K, Ledgerwood D, Hope KM, Kennedy A (2000) Comparison of higher-dose intradermal hepatitis b vaccination to standard intramuscular vaccination of healthcare workers. Infect Control Hosp Epidemiol 21:264–269
Alarcon JB, Hartley AW, Harvey NG, Mikszta JA (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14:375–381
Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE (2007) Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 25:6755–6763
Acknowledgments
The authors would like to acknowledge the Corium team for their various efforts towards developing the MicroCor technology platform and products. The authors would also like to gratefully acknowledge Raymond Daynes of the University of Utah for collaborating on the rPA studies.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Singh, P., Chen, G., Worsham, W. (2013). MicroCor® Transdermal Delivery System: A Safe, Efficient, and Convenient Transdermal System for Vaccine Administration. In: Singh, M. (eds) Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-5380-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5380-2_11
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-5379-6
Online ISBN: 978-1-4614-5380-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)